NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
This grant funds early phase clinical trials focused on natural products.
About this program
The NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) is designed to support innovative research that explores the efficacy and safety of natural products in clinical settings. This grant is aimed at researchers and institutions that are conducting early phase clinical trials to evaluate the therapeutic potential of natural products. The funding will facilitate the development and testing of these products, which may include herbal medicines, dietary supplements, and other natural substances. Eligible applicants include academic institutions, nonprofit organizations, and other research entities that have the capability to conduct clinical trials. The grant encourages collaboration among researchers and institutions to enhance the quality and impact of the research. By providing financial support for these trials, the NCCIH aims to advance the understanding of natural products and their potential benefits in healthcare.
Eligibility
Academic institutions, nonprofit organizations, and research entities capable of conducting clinical trials.